ID

23259

Descrizione

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Keywords

  1. 28/06/17 28/06/17 -
  2. 01/07/17 01/07/17 -
Titolare del copyright

Genentech, Inc.

Caricato su

1 luglio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    Patient administration
    Descrizione

    Patient administration

    Subject Number
    Descrizione

    PT

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Subject Initials:
    Descrizione

    PTINIT

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C1997894
    UMLS CUI [1,2]
    C2986440
    Report Date:
    Descrizione

    VDT

    Tipo di dati

    date

    Alias
    UMLS CUI [1,1]
    C1302584
    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
    Descrizione

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)

    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    Descrizione

    TX_DRUG_DISC [TXDISC]

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C2826674
    Date Subject Discontinued Study Drug Treatment Early:
    Descrizione

    TX_DISCONTINUED_DT [TXDCDT]

    Tipo di dati

    date

    Unità di misura
    • DD/MMM/YY
    Alias
    UMLS CUI [1,1]
    C0558681
    UMLS CUI [1,2]
    C0011008
    DD/MMM/YY
    Check the PRIMARY reason the subject discontinued study drug treatment early
    Descrizione

    TX_DRUG_DISC_REASON [TXREAS]

    Tipo di dati

    integer

    Alias
    UMLS CUI [1,1]
    C0558681
    UMLS CUI [1,2]
    C0566251
    Please specify intervention:
    Descrizione

    TX_DISC_REASON_SP [TXDCRS]

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0558681
    UMLS CUI [1,2]
    C0566251
    UMLS CUI [1,3]
    C0184661

    Similar models

    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)CRFs Roche FVF4168G Macular Edema NCT00473330

    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Patient administration
    PT
    Item
    Subject Number
    integer
    C2348585 (UMLS CUI [1])
    PTINIT
    Item
    Subject Initials:
    text
    C1997894 (UMLS CUI [1,1])
    C2986440 (UMLS CUI [1,2])
    VDT
    Item
    Report Date:
    date
    C1302584 (UMLS CUI [1,1])
    Item Group
    STUDY DRUG TREATMENT COMPLETION / EARLY DISCONTINUATION (UNSCHEDULED)
    Item
    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    integer
    C2826674 (UMLS CUI [1])
    Code List
    Indicate if the subject completed the study drug treatment or discontinued early (check one only):
    CL Item
    Subject Completed Study Drug Treatment (1)
    CL Item
    Subject Discontinued Study Drug Treatment Early (2)
    TX_DISCONTINUED_DT [TXDCDT]
    Item
    Date Subject Discontinued Study Drug Treatment Early:
    date
    C0558681 (UMLS CUI [1,1])
    C0011008 (UMLS CUI [1,2])
    Item
    Check the PRIMARY reason the subject discontinued study drug treatment early
    integer
    C0558681 (UMLS CUI [1,1])
    C0566251 (UMLS CUI [1,2])
    Code List
    Check the PRIMARY reason the subject discontinued study drug treatment early
    CL Item
    Adverse Event (complete appropriate Adverse Event CRF) (1)
    CL Item
    Death (complete Study Completion / Early Discontinuation CRF) (2)
    CL Item
    Lost to follow-up (3)
    CL Item
    Physician’s decision to discontinue treatment (for reasons other than AE) (4)
    CL Item
    Subject’s decision to discontinue treatment (for reasons other than AE) (5)
    CL Item
    Sponsor’s decision to terminate study (6)
    CL Item
    Pregnancy (complete Pregnancy CRF) (7)
    CL Item
    Subject non-compliance (8)
    CL Item
    Subject’s condition mandated other therapeutic intervention (9)
    Item
    Please specify intervention:
    text
    C0558681 (UMLS CUI [1,1])
    C0566251 (UMLS CUI [1,2])
    C0184661 (UMLS CUI [1,3])
    Code List
    Please specify intervention:

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial